Stay updated on Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6, representing a system software update from the previous revision. This change updates the site's metadata but does not affect study content or how information is presented to users.
    Difference
    0.1%
    Check dated 2026-08-31T17:36:19.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision tag on the page updated to v3.6.5, signaling a newer version of the page or template. No study details or visible content are affected by this update.
    Difference
    0.1%
    Check dated 2026-08-10T13:48:28.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.6.4 is now displayed on the page, replacing the previous Revision: v3.6.3. This indicates a minor platform update with no changes to the study details or visible content.
    Difference
    0.1%
    Check dated 2026-07-27T06:19:21.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page now displays an updated revision tag (Revision: v3.6.3), replacing the previous Revision: v3.6.2.
    Difference
    0.1%
    Check dated 2026-07-05T15:37:55.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    A new revision tag (v3.6.2) was added and the previous tag (v3.6.0) removed, indicating a platform software update.
    Difference
    0.1%
    Check dated 2026-06-28T08:43:01.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Recruitment status now shows no more participants; new user guidance sections were added, and the Intervention/Treatment header formatting was updated to reflect the current structure of the study details.
    Difference
    0.4%
    Check dated 2026-06-14T05:14:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.